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Fecal microbiota transplantation (FMT) is an effective treatment for
recurrent Clostridioides difficile infection (rCDI) and it’s also considered for treating
other indications. Metagenomic studies have indicated that commensal donor bacteria
may colonize FMT recipients, but cultivation has not been employed to verify strain-level
colonization. We combined molecular profiling of Bifidobacterium populations with
cultivation, molecular typing, and whole genome sequencing (WGS) to isolate and
identify strains that were transferred from donors to recipients. Several Bifidobacterium
strains from two donors were recovered from 13 recipients during the 1-year follow-up
period after FMT. The strain identities were confirmed by WGS and comparative
genomics. Our results show that specific donor-derived bifidobacteria can colonize
rCDI patients for at least 1 year, and thus FMT may have long-term consequences for
the recipient‘s microbiota and health. Conceptually, we demonstrate that FMT trials
combined with microbial profiling can be used as a platform for discovering and isolating
commensal strains with proven colonization capacity for potential therapeutic use.
Keywords: C. difficile, stool transplantation, intestinal microbiota, strain tracking, whole genome sequencing,
comparative genomics, therapeutic bacteria, next-generation probiotics
INTRODUCTION
In fecal microbiota transplantation (FMT), feces from a healthy donor is transplanted into a
recipient in order to re-establish a healthy or normally functioning gut microbiota and to correct
microbiota dysbiosis associated with the recipient’s condition. FMT has been highly effective in
treating recurrent Clostridioides difficile infection (rCDI) and it is increasingly employed and
recommended treatment for the disease (Surawicz et al., 2013; Cammarota et al., 2017). Gut
microbiota of rCDI patients has generally a lower bacterial diversity and different taxonomical
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composition when compared to healthy individuals (Chang
et al., 2008; Seekatz and Young, 2014). In rCDI patients, a
successful treatment with FMT leads to increased microbial
diversity and modified composition (Fuentes et al., 2014; Seekatz
et al., 2014). Currently, rCDI is the only indication for FMT
in clinical practice (Cammarota et al., 2017, 2019), but the
treatment has shown promising results in other conditions
where gut microbiota plays a role, such as inflammatory bowel
disease (IBD), metabolic syndrome, and eradication of antibiotic
resistant bacteria (Browne and Kelly, 2017; De Groot et al.,
2017; Laffin et al., 2017). Several studies have demonstrated that
microbiota of an FMT-treated rCDI patient is very similar to
that of the donor, and there have been efforts to identify the
commonly colonizing taxa along with specific set of bacteria
that might be crucial for the success of such treatment (Jalanka
et al., 2016; Staley et al., 2016). In indications such as IBD, the
identity of specific bacteria may be even more important as early
reports indicate that success may depend on the microbial profile
of the donor (Moayyedi et al., 2015; Browne and Kelly, 2017).
Thus, the potential of FMT in modifying gut microbiota, as well
as the specific colonization of donor-derived taxa, has gained
considerable interest. Donor strains that are able to colonize
recipients in long-term are of special interest, as they might
show potential for being so-called next-generation probiotics,
i.e., therapeutic bacteria for the treatment of diseases in which
dysbiosis is considered to play a role.
One study investigated the fate of donor-derived bacterial
strains by shotgun-metagenomics and single nucleotide variant
(SNV) analysis to track several bacterial species in five
FMT-treated metabolic syndrome patients (Li et al., 2016).
Considerable variation was observed in the transfer and
persistence of donor-derived bacteria. Some donor strains either
replaced or co-existed with the recipient strains, while some
donor bacteria were not detected in recipient metagenomes.
Interestingly, the colonization patterns were not similar among
the recipients as individuals seemed to adopt donor-derived
bacteria in a different manner. However, several donor strains
were still detectable in all five recipient metagenomes 84 days
post-FMT. The varied colonization of donor-derived species was
also reported in a study comparing post-FMT metagenomes of
seven rCDI patients, also by using SNV analysis (Kumar et al.,
2017). Several donor-derived strains were detected in all seven
recipients from 3 to 6 months post-FMT and a few strains were
detected in two recipient metagenomes even 2 years after FMT.
Thus, it seems that at least some donor-derived bacteria may
colonize FMT recipients relatively permanently. More recently,
a study combining metagenomics, strain identification based on
single copy phylogenetic markers, and machine learning model
assessed the colonization of donor bacteria in FMT recipients
(Smillie et al., 2018). A total of 125 donor-derived strains
were detected in the recipient metagenomes after FMT with
58 of these strains being detectable over a month post-FMT.
Interestingly, closely related bacterial strains were observed to
transfer mostly as sets in which all the strains of a distinct
species were colonized, depending on the recipient, either in
unison or not at all. Although several studies have addressed
the colonization of non-pathogenic commensal donor bacteria
by metagenomics, none of them has actually recovered donor
strains from the recipients as pure cultures that would allow a
precise strain identification and possible further use of effectively
colonizing strains.
In this study, our aim was to assess the long-term colonization
of donor-derived bifidobacteria in FMT recipients by combining
culture-independent and culture-dependent methods. The study
subjects comprised two FMT donors and thirteen rCDI patients.
Sampling was performed prior to FMT as well as at various time
points during the 1-year follow-up period. First, we analyzed
fecal bifidobacterial populations of the donors and recipients by a
genus-specific molecular profiling technique to detect putatively
donor-derived bifidobacteria in the post-FMT samples of the
recipients. Next, we isolated bifidobacteria from the samples of
donors and recipients, and screened the bifidobacterial isolates
by using rep-PCR typing. Finally, we selected 65 isolates for whole
genome sequencing and comparative genomic analysis to identify
the donor-derived strains among the recipient isolates.
MATERIALS AND METHODS
FMT Donors and Recipients and Fecal
Samples
Fecal samples (n = 112) originate from two FMT donors
(DX and DY) and their thirteen recipients (DX: PX1–7,
DY: PY1–6). The samples are presented in Supplementary
Table 1. The recipients were rCDI patients successfully
treated with FMT. Subjects and sampling have been
described in detail earlier (Jalanka et al., 2016). Recipients
donated a fecal sample prior to FMT as well as at
different time points covering the 1-year follow-up period
(Supplementary Table 1). Feces were stored at −80◦C
until the analyses.
DNA Extractions
DNA extraction for Bifidobacterium-specific PCR-DGGE
profiling of fecal samples included mechanical cell-lysis step
by repeated bead-beating method described earlier (Salonen
et al., 2010). DNA was purified from proteins with ammonium
acetate, precipitated with isopropanol, washed with ethanol,
and suspended in TE buffer. Genomic DNA (gDNA) of isolates
for partial 16S rRNA gene sequencing, rep-PCR, and WGS by
MiSeq was extracted with the same method from liquid cultures.
Bacteria were grown in liquid MRS medium (BD) supplemented
with 0.5 gl−1 of L-cysteine (Sigma-Aldrich) at 37◦C for 48 ± 4
h under anaerobic atmosphere (85%N2, 10%CO2, and 5%H2).
Bacterial pellets were harvested by centrifugation and suspended
in RBB buffer. For WGS by PacBio, gDNA was extracted from
cultures in midpoint logarithmic growth with MagAttract kit
(Qiagen) according to the manufacturer’s instructions, preceded
by 2-h chemical cell-lysis with MetaPolyzyme enzyme mixture
(Sigma-Aldrich). DNA concentrations were determined with
NanoDropTM ND-1000 Spectrophotometer (Thermo Scientific)
or Qubit R©2.0 fluorometer with Qubit dsDNA HS Assay kit
(Thermo Scientific) according to the manufacturer’s instructions.
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PCR-DGGE Profiling
Bifidobacterial profiles of 112 fecal samples were analyzed by
genus-specific PCR and denaturing gradient gel electrophoresis
(DGGE) as described earlier (Satokari et al., 2001). Briefly, 5pmol
of Bifidobacterium-specific primers Bif164-forward and Bif662-
GC-reverse (Satokari et al., 2001) were added in reaction mixture
of 25 µl containing 12.5 µl KAPA2G Robust HotStart ReadyMix
(Kapa Biosystems) or MyTaq HS Red Mix (Bioline) and 1–150
ng DNA extracted from a fecal sample. If this failed, above-
described PCR was done from 16S amplicon mixture produced
with primers Bif164-forward and Bif662-reverse (Satokari et al.,
2001) and called nested. Thermal cycler program was: 95◦C for 3
min; 35 cycles of 95◦C for 15 s, 62◦C for 15 s, and 72◦C for 15 s;
and 72◦C for 5 min. Amplicons were separated in polyacrylamide
gels (Satokari et al., 2001) and DNA was stained with SYBR
Green (BioWhittaker).
Digitalized gel images were imported into Bionumerics
software (version 6.6; Applied Maths) for band detection with
normalization conducted by known reference amplicons. After
band search and matching (1% band tolerance as implemented
in Bionumerics), the results were checked visually and corrected
manually when necessary. The profiles were put through cluster
analysis with unweighted pair group method with arithmetic
mean (UPGMA) for constructing dendrogram based on Pearson
correlation similarity coefficient, as implemented in Bionumerics.
Data matrices containing band presence/absence information
were exported to R (version 3.5.0; The R Foundation for
Statistical Computing) for further analysis of clustering and
sample similarity. Dissimilarity matrix was computed with daisy
function from R-package cluster using Gower’s distance. Multiple
correspondence analysis was performed by MCA function in
R-package FactoMineR, and R-package factoextra functions
fviz_mca_ind and fviz_contrib were used for visualization
of sample clustering and contribution of variables in MCA,
respectively. Statistically significant groups contributing to the
sample clustering were identified by PERMANOVA analysis in
adonis function from R-package vegan (Oksanen et al., 2018)
using Bray-Curtis dissimilarities and 999 permutations.
Isolation of Bifidobacteria and Tentative
Identification
A subset of fecal samples used for PCR-DGGE profiling was
selected for cultivation (n = 30; Supplementary Table 1). The
subset included samples from the recipients whose profiles had
indicated the presence of putative donor-derived bifidobacteria at
different time points post-FMT. For each selected recipient, the
sample at the latest post-FMT time point with putative donor-
derived bifidobacteria was cultivated in order to isolate strains
with long-term colonization capacity as well as one to three
samples at earlier time points for strain comparison, including
the pre-FMT sample if available. The subset included one sample
from both donors whose profiles had been stable during the
1-year follow-up.
Cultivation was performed as described earlier (Quartieri
et al., 2016) with slight modifications. Briefly, fecal samples
were weighed and suspended 1:10 (w/v) in phosphate-buffered
peptone water (Sigma-Aldrich) supplemented with 0.5 gl−1 of
L-cysteine (Sigma-Aldrich). Next, 10-fold dilutions up to 10−7
were spread onto solid MRS medium (BD) supplemented with 0.5
gl−1 of L-cysteine (Sigma-Aldrich) and 0.05 gl−1 of mupirocin
(Sigma-Aldrich) and grown at 37◦C for 48± 4 h under anaerobic
atmosphere. Several colonies of each type were picked from
the lowest dilutions yielding single colonies. 163 isolates from
purified cultures were examined for colony morphology, Gram
reaction, and cell morphology. 10 isolates were discarded as they
did not meet the criteria for bifidobacteria (Gram positive rods
of various morphologies), and the remaining 153 isolates were
subjected to taxonomic identification.
Taxonomic identification was done for isolates (n = 153)
by sequencing a fragment of 16S rRNA gene. PCR mixtures
of 25 µl contained 3.0 mM MgCl2, 0.2 mM dNTPs, 0.4 µM
universal primers DegL, and pD (Turner et al., 1999) 1.0 U
AmpliTaq Gold R© DNA polymerase (Applied Biosystems by Life
Technologies), and 50–100 ng gDNA. Thermal cycler program
was: 96◦C for 2 min; 30 cycles of 96◦C for 30 s, 56◦C for 45 s,
and 72◦C for 1 min; 72◦C for 5 min. Amplicons were Sanger
sequenced in the Institute of Biotechnology (IB) at University
of Helsinki (Helsinki, Finland) (UH) according to the institute’s
protocols. The .ab1 trace files were processed with Staden Package
software components pregap4 (version 1.6) and gap4 (version
4.11.2) (Bonfield et al., 1995). The resulting sequences were used
as queries to search matches from the NCBI 16S ribosomal
RNA nucleotide database by basic local alignment search tools
(BLAST) megaBLAST algorithm (Morgulis et al., 2008) to assign
species-level taxonomic identities. 6 isolates were discarded as
they were not representatives of the genus Bifidobacterium, and
the remaining 147 isolates were subjected to rep-PCR typing.
Rep-PCR Typing
The isolates confirmed as Bifidobacterium sp. (n = 147) were
typed by repetitive extragenic palindromic PCR (rep-PCR)
(Jarocki et al., 2016). Briefly, the gDNAs were amplified with
the BOXA1R primer (Jarocki et al., 2016). PCR mixtures of 20
µl contained 3.0 mM MgCl2, 0.2 mM dNTPs, 1.0 µM primer,
1.0 U AmpliTaq Gold R© DNA-polymerase (Applied Biosystems by
Life Technologies), and 50 ng gDNA. Thermal cycler program
was: 94◦C for 4 min; 35 cycles 94◦C for 1 min, 40◦C for 1
min, 72◦C for 2 min; 72◦C for 10 min. The amplicons were
electrophoresed in 1.4% agarose gel in TBE buffer at 120 V for
75 min for visualization.
Whole Genome Sequencing
A subset of bifidobacterial isolates (n = 65; Supplementary
Table 2) was selected for whole genome sequencing (WGS).
The subset included donor isolates from all the different rep-
PCR fingerprint types in order to verify tentative species-level
identification as well as to observe within-species variation as
indicated by the fingerprints. As the aim was to assess long-term
colonization by donor strains, the subset included all but one
recipient isolates that were considered donor-like by rep-PCR
typing and were recovered from the time point of 4 months or
beyond. The subset was supplemented with several similar and
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dissimilar recipient isolates of these species from different time
points to bring about resolution in the whole genome analyses.
gDNA of 65 isolates were sequenced by Illumina MiSeq
from Nextera XT genomic libraries (Illumina, Inc.) in the
Institute for Molecular Medicine (FIMM) or in IB at UH with
manufacturer protocols. The quality of sequences was checked
with FastQC quality control tool (Andrews, 2010) and trimmed
with Trimmomatic (Bolger et al., 2014) to remove adapters and
cut low quality ends. The trimmed sequences were assembled
into contigs with Spades (v3.13.0) assembly pipeline for paired
sequences with k-mer lengths 21, 33, 55, 77, 99, and 127 (Nurk
et al., 2013). In addition, two of the genomes were also sequenced
with PacBio RSII (Pacific Biosciences of California, Inc.) using
DNA/Polymerase binding kit P6 and assembled with HGA3
(SMRTportal 2.3.0) followed by polishing of the assemblies with
MiSeq reads by Pilon-software (v1.23) (Walker et al., 2014) in
the IB at UH. The quality of assemblies was analyzed by QUAST
online-tool1 (Gurevich et al., 2013). In identifying the closest
matches from the NCBI RefSeq genome database2, all the donor
strain assemblies were converted into single-line FASTA files that
were used as queries in BLAST search (Altschul et al., 1990).
Comparative Genomics
Phylogenetic relationships of all the isolates (n = 65) and NCBI
reference genomes (closest BLAST hits, listed in Supplementary
Table 5) were studied with a phylogenomic approach by using
command line tools of Anvi’o workflow (v5.5)3 (Eren et al., 2015)
and FastTree (v2.1.10) (Price et al., 2010). FastTree implements
an approximately-maximum-likelihood based approach, and
it was used with default options, including 1,000 bootstraps.
Briefly, after running the default HMM profiles, concatenated
amino acid sequences of 49 single-copy genes of ribosomal
proteins were aligned as implemented in the Anvi’o pipeline.
Phylogenomic tree was constructed from the alignment by
FastTree (v2.1.10) and visualized with FigTree (v1.4.4) (Rambaut,
2010). For whole genome SNP calling and construction of
phylogenetic trees, we used CSIPhylogeny online-tool (v1.4)4
(Kaas et al., 2014). The two donor strain PacBio assemblies
(DX_pv5PacBio and DX_pv32PacBio) were used as references
against which the spades-assembled draft genomes of B. longum
and B. pseudocatenulatum isolates were aligned with default
parameters. A similar analysis was done for B. adolescentis
isolates with the draft genome of DX_pv1 serving as reference.
Trees were visualized with FigTree (v1.4.4) (Rambaut, 2010).
Finally, the relationships of all the isolates were estimated by
pangenomic analysis. The distribution of gene clusters across
the genomes was estimated and visualized with command line
tools of Anvi’o workflow (v5.5) for microbial pangenomics5. In
the pipeline, blastp was chosen for search, MCL (Enright et al.,
2002) for clustering, and muscle (Edgar, 2004) for alignment.
Predicted proteins were functionally categorized based on their
1http://quast.sourceforge.net/quast
2https://www.ncbi.nlm.nih.gov/refseq/
3http://merenlab.org/2017/06/07/phylogenomics/
4https://cge.cbs.dtu.dk/services/CSIPhylogeny/
5http://merenlab.org/2016/11/08/pangenomics-v2/
clusters of orthologous groups (COGs) (Galperin et al., 2015)
and visualization of pangenome was drawn based on the
presence/absence of gene clusters.
Ethical Considerations
The study was approved by the Ethics Committee of
Hospital District of Helsinki and Uusimaa Finland
(DnroHUS124/13/03/01/11). The fecal donors and rCDI patients
provided written informed consent to take part in the study.
Data Availability
The whole genome sequencing data supporting the findings of
this study have been deposited in European Nucleotide Archive
(ENA) under study accession number: PRJEB35833. All other
types of data generated or analyzed during this study are included
in this article and its Supplementary Information.
RESULTS
Bifidobacterium-Specific 16S rRNA Gene
Profiles Suggest Transfer of Donor
Bifidobacteria to FMT Recipients
Bifidobacterial profiles of the donors were both distinct and stable
over time (Supplementary Figure 1). The profile of donor DY
consisted of two bands that were in the same positions as those
obtained from the donor’s B. longum and B. pseudocatenulatum
isolates. The profile of donor DX was more complex, consisting
of four or five bands during the 1-year follow-up period with
a small change toward the end. The bands matched with
those resulting from the donor’s B. adolescentis, B. longum, and
B. pseudocatenulatum isolates.
Most of the recipient pre-FMT samples differed from all
the other samples and clustered separately in the UPGMA
cluster analysis, whereas many of the post-FMT samples grouped
with the profiles of their respective donor (Supplementary
Figure 1). Clustering of samples to the groups X or Y (samples
of DX and DY and their respective recipients PX and PY)
explained 20% (p = 0.001) of the post-FMT sample separation
in MCA, whereas clustering to the groups D or P (donor or
recipient) explained 7% of the separation (p = 0.001) (Figure 1A).
The top five variables explaining the clustering of post-FMT
samples in MCA included several bands matching the positions
of those derived from the donor isolates, including all three
analyzed B. longum donor isolates (Figure 1B). Thus, donor-
recipient pairing influenced the clustering of the bifidobacterial
PCR-DGGE profiles substantially, and the appearance of bands
corresponding to the donor B. longum isolates contributed to the
clustering the most.
Donor-Like Bifidobacteria Were Isolated
From FMT Recipients
Based on the results obtained from PCR-DGGE profiling, we
chose one fecal sample from each of the donors and 28
from selected recipients (n = 30; Supplementary Table 1) for
selective cultivation of bifidobacteria. Cultivation was successful
Frontiers in Microbiology | www.frontiersin.org 4 July 2020 | Volume 11 | Article 1663
fmicb-11-01663 July 13, 2020 Time: 15:30 # 5
Jouhten et al. Bifidobacteria in Fecal Transplantation
FIGURE 1 | Clustering of Bifidobacterium-specific PCR-DGGE profiles obtained from fecal samples of FMT donors and their recipients at different time points.
(A) MCA plot of the recipient post-FMT samples and donor samples. (B) The five band positions contributing the most to each dimension of MCA. DGGE,
denaturing gradient gel electrophoresis; MCA, multiple correspondence analysis; DX and DY, FMT donors; PX1-7 and PY1-6, FMT recipients of DX and DY,
respectively. Fecal sample time points for recipients and DY: F0, pre-FMT (the time of donation for DY); F1–F7, 3 days, 2 weeks, 1, 2, 4, 8, and 12 months post-FMT,
respectively; Time points for DX: F3, the time of donation; F4, F5, F7, F10, F13, and F14, 2 weeks, 1, 2, 4, 8, and 12 months post-FMT, respectively.
from both donor samples and most of the recipient samples
(23 out of 28) (Supplementary Table 3). The five negative
recipient samples included two pre-FMT samples. A total of
153 bacterial isolates from the cultures were subjected to
taxonomic identification by partial 16S rRNA gene sequencing
with 147 isolates confirmed as Bifidobacterium spp. Altogether
eight different species were represented among the isolates
(Supplementary Table 2). Recipient pre-FMT samples were
scarce in bifidobacteria: only one yielded isolates and they
belonged to species that were not recovered from either of the
donors (Supplementary Table 2) while the other cultivated pre-
FMT samples were negative for bifidobacteria (Supplementary
Table 3). The bifidobacterial isolates of same species exhibited
similar phenotypic properties (colony and cell morphology;
Supplementary Table 2). The overall variety of different species
in the cultivated samples reflected the results obtained from PCR-
DGGE profiling (Supplementary Table 3). Next, we subjected
the isolates to rep-PCR typing in which 19 different fingerprint
profiles were identified (Supplementary Table 2). Nine distinct
rep-PCR fingerprint profiles were observed among the donor
isolates revealing within-species variation and thus allowing
resolution below species level (Figure 2A).
Two species of bifidobacteria were isolated from the donor DY
and all the isolates within the same species had a similar rep-
PCR fingerprint: B. longum (DY-2) and B. pseudocatenulatum
(DY-1) (Figure 2A). Comparison of the donor and recipient
isolates revealed that all three DY recipients carried DY-2-like
B. longum 1 year after FMT (Figure 2B). However, no donor-like
isolates of B. pseudocatenulatum were recovered from any of
the DY recipients (Figure 2B). All the recipients carried also
bifidobacterial species that were not isolated from the donor
(Supplementary Table 2).
Donor DX had five bifidobacterial species and seven
different rep-PCR fingerprints: B. adolescentis (DX-1),
B. animalis (DX-4), B. bifidum (DX-3), B. longum (DX-
2, DX-18, DX-23), and B. pseudocatenulatum (DX-5)
(Figure 2A). All six recipients of DX had donor-like
isolates after FMT (Figure 2B). Some recipients carried
also unique strains of these species and one recipient had
a species not isolated from the donor (Supplementary
Table 2). The most prevalent donor-like isolates recovered
from the recipients at the end of the 1-year follow-up
period were strains of B. longum (DX-2, DX-18, or DX-
23; Figure 2B). Donor-like B. adolescentis (DX-1) was
also detected in one recipient 1 year post-FMT. Donor-like
B. pseudocatenulatum (DX-5) was detected in multiple recipients
up to 4 months post-FMT.
Whole Genome Sequencing Verifies the
Same Origin of Donor and Recipient
Isolates
We subjected 65 bifidobacterial isolates (19 from the donors
and 46 from the recipients; Supplementary Table 2) to WGS
to assess the similarity of isolates by three different approaches:
phylogenomics, phylogenetics, and pangenomics. The genome
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FIGURE 2 | Rep-PCR typing of bifidobacteria isolated from fecal samples of FMT donors and recipients. (A) Representative gel pictures presenting rep-PCR
fingerprint profiles of bifidobacterial isolates from donors DY and DX and their respective recipients PY5 and PX1 at different time points: PY5 has unique profiles
pre-FMT, but also DY-like profiles post-FMT (upper gel). PX1 has DX-like profiles post-FMT (lower gel). (B) A visual summary of donor-like rep-PCR fingerprint profiles
observed among each recipient’s isolates during the 1-year follow-up after FMT. Each colored dot refers to a distinct type of rep-PCR fingerprint profile observed
among the donor isolates. A profile was indexed based on the first isolate to have that profile. For instance, purple dot representing profile B. longum DX-2 was
indexed according to the donor isolate B. longum DX_pv2 in which the profile was encountered for the first time. If such profile was observed in a recipient isolate,
the isolate was considered donor-like and received the same color. For instance, recipient isolate B. longum PX1_F7pv1 was observed to have B. longum DX-2
profile and received the purple color. Thus, all the donor and donor-like isolates with the same profile were considered representatives of a same rep-PCR profile
group and putatively being of the same origin. All the profiles observed among recipient isolates but not in donor isolates were referred collectively with a black
square (A). PY1 and PY4-5, FMT recipients of DY; PX1-4 and PX6-7, FMT recipients of DX. The isolate code includes reference to the sample from which it was
isolated, see Supplementary Table 2. M, GeneRulerTM DNA Ladder Mix; N, negative PCR control.
size, G+C content, and predicted gene count of all the isolates
are presented in Supplementary Table 4. The assembly statistics
of all the donor isolates along with the closest taxonomic matches
obtained from the NCBI RefSeq genome database are presented
in Supplementary Tables 4, 5, respectively.
To address the relatedness of the isolates we performed a
phylogenomic analysis based on the alignment of concatenated
amino acid sequences derived from 49 ribosomal protein
genes for construction of phylogenetic tree. The isolates
were clearly separated from the NCBI RefSeq genomes while
displaying donor-strain-wise clustering (Figure 3A). Donor
DX B. longum isolates representing the three different rep-
PCR fingerprint groups separated into distinct phylogenetic
clusters. Similarly, the two donor DY B. longum isolates
with identical rep-PCR fingerprints clustered together. Several
recipient isolates clustered together with the similar isolates from
their respective donor.
To analyze the relatedness among B. adolescentis, B. longum,
and B. pseudocatenulatum isolates from the donors and
recipients more closely, the genomes were subjected to
whole genome SNP calling to construct phylogenomic
trees for each of the species. Phylogenomic groups were
in accordance with the rep-PCR fingerprinting results:
DX B. longum isolates and the similar recipient isolates
were distributed into corresponding three groups (DX-
2, DX-18, and DX-23 group) (Figure 3B). Likewise,
the DY B. longum isolate and similar recipient isolates
comprised their own group (DY-2 group). A group of
recipient B. longum isolates not sharing a similar rep-
PCR profile with the donor isolates comprised a separate
group. In the phylogenomic trees of B. adolescentis and
B. pseudocatenulatum, the isolates grouped according to
their rep-PCR fingerprints (Supplementary Figure 2). SNP
calling found 2213940–2273604, 2055193–2656944, and
2059398–2475233 positions for comparison among the genomes
of B. adolescentis, B. longum, and B. pseudocatenulatum,
respectively, and thus, the coverage of SNP analysis was
as high as 75–99% of the genome lengths. The number
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FIGURE 3 | Phylogenetic trees of fecal bifidobacterial isolates from FMT donors and their recipients. (A) Phylogenomic tree based on concatenated amino acid
sequences of 49 single copy genes of ribosomal proteins of all the isolates and NCBI reference genomes. Note that the tree is topological and branch distance is
therefore unindicative of phylogenetic distance. (B) Phylogenetic tree of B. longum isolates based on whole genome SNP calling. The colors in isolate codes indicate
an isolate’s rep-PCR fingerprint group. The branch support values represent proportions among 1,000 bootstraps. DX and DY, FMT donors; PX1-4 and PX6-7, FMT
recipients of DX; PY1 and PY5 , FMT recipients of DY. F1, F2, F4, F5, and F7, 3 days, 2 weeks, 2, 4, and 12 months post-FMT, respectively; pv1-54, isolate codes;
DX_pv5_PacBio and DX_pv32_PacBio, two DX isolate genomes that were sequenced by PacBio in addition to MiSeq; REF, reference strains from the NCBI
reference genome database (Supplementary Table 5).
of SNPs that separated clearly different strains (NCBI
RefSeq genomes and the isolates originating from different
donors) was about 7,000–8,000, whereas some isolates had
only a few different SNPs indicating very close relatedness
(Supplementary Table 6).
The SNP analysis revealed that the isolates clustering
most closely in the trees were separated only by few or few
hundred SNPs (Supplementary Table 6). In the B. longum
DX-23 group, the difference between the donor isolates
(DX_pv23, DX_pv48, and DX_pv53) and the four isolates
from different recipients was less than ten SNPs. One of these
recipient isolates (PX6_F7pv2) was recovered from 1-year
post-FMT sample. The B. longum DX-18 group comprising
two donor-isolates (DX_pv18 and DX_pv36) and eight
recipient isolates had a corresponding difference up to 500
SNPs. Three of these recipient isolates originated from the
1-year post-FMT samples of two recipients (PX1_F7pv2
and PX1_F7pv4 separated by 165–187 SNPs from DX_pv36
and PX6_F7pv1 separated by 324 SNPs from DX_pv18).
The donor strains of B. longum DY-2 group (DY_pv2 and
DY_pv11) clustered together with three recipient isolates
of which one originated from a 1-year post-FMT sample
(PY1_F7pv1 separated from the donor isolates by some 200
SNPs; Supplementary Table 6).
We also conducted a pangenome analysis to view the
differences in the distribution of gene clusters among
all the isolates. The pipeline estimated that the genomes
were 97–98.5% complete and revealed genome sizes, G+C
content, and gene numbers as shown in Supplementary
Table 4. An average gene cluster number per genome was
2024 (min. 1562, max. 2369). The shared part of genomes
(belonging to the core genome of all the isolates) consisted
of 800 gene clusters containing 540 single-copy core gene
clusters coding mainly known clusters of orthologous groups
(COGs) (Figure 4). The accessory genome varied between
the genomes and contained more clusters with unknown
COGs. Importantly, the pangenome analysis separated
the genomes into groups that were in accordance with
the rep-PCR fingerprint groups of the isolates as well as
with the groups displayed by phylogenetic trees, and thus
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FIGURE 4 | Visual comparison of genomic content of all the 65 sequenced bifidobacterial isolates from FMT donors and their recipients. Colored brackets with
group labels refer to the rep-PCR fingerprint groups. The upper layer presents genomic content with known and unknown clusters of orthologous groups (COGs) in
green and white, respectively. The second layer presents core genome as single copy gene (SCG) functions in dark brown. DX and DY, FMT donors; PX1-4 and
PX6-7, FMT recipients of DX; PY1 and PY5, FMT recipients of DY; F1, F2, F4, F5, and F7, 3 days, 2 weeks, 2, 4, and 12 months post-FMT, respectively; pv1-54,
isolate codes; DX_pv5_PacBio and DX_pv32_PacBio, two DX isolate genomes that were sequenced by PacBio in addition to MiSeq; *, B. animalis isolate; **,
B. adolescentis isolate not belonging to the DX-1 group.
further confirmed the similarity of strains isolated from
each of the donor and their corresponding recipients. In
summary, all our analyses demonstrated that strains of
donor groups B. adolescentis DX-1, B. longum DX-18,
B. longum DX-23, and B. longum DY-2 were recovered
from the recipients until a year after FMT and strains of
donor group B. pseudocatenulatum DX-5 until 4 months
post-FMT.
DISCUSSION
FMT is an effective treatment for rCDI and its capacity to
modify recipient gut microbiota to donor-like configuration is
well-established (Khoruts et al., 2010; Weingarden et al., 2015;
Broecker et al., 2016; Fuentes and De Vos, 2016; Jalanka et al.,
2016). However, the fate of specific donor strains in the gut
microbiota of recipients is still unclear (Shankar et al., 2014;
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Broecker et al., 2016; Moss et al., 2017; Staley et al., 2017). Recent
metagenomic studies and SNV mapping have addressed this
question and indicated presence of donor strains in recipients for
several months after FMT (Li et al., 2016; Kumar et al., 2017; Lee
et al., 2017; Smillie et al., 2018). Recently, Drewes et al. (2019)
assessed the presence of bacterial virulence factors up to 6 months
after FMT in eleven pediatric rCDI patients and their respective
donors by fecal cultures and quantitative PCR, and the results
indicated durable transmission. However, the strain verification
by WGS was done only in one patient-donor-pair. Another recent
study revealed the transfer of extended-spectrum beta-lactamase
(ESBL) producing Escherichia coli to two recipients from one
fecal donor who had not been pre-screened for the pathogen
(Defilipp et al., 2019). While these studies employed cultivation
and WGS to demonstrate the transfer of donor bacteria to
recipients, our study greatly extends the previous observations
by involving more donor-recipient-pairs as well as having a
longer follow-up period and a larger number of studied isolates.
Our study is the first one to demonstrate the transfer of non-
pathogenic commensal bacteria in several donor-recipient-pairs
by cultivation and strain verification by WGS. Furthermore, we
were able to demonstrate the long-term colonization of donor-
derived strains in the FMT recipients as specific strains were
detected in multiple recipients even up to 1 year post-FMT.
We targeted fecal bifidobacterial populations in FMT donors
and recipients by genus-specific PCR-DGGE profiling at different
time points during a 1-year period. The method allows a rapid
assessment of changes occurring in a specific group of bacteria
and it is well suited for bifidobacterial population dynamics at
an individual level (Satokari et al., 2001). The donor profiles
were stable over time, which is in accordance with previous
observations on bifidobacterial populations in healthy Western
adults (Satokari et al., 2001; Rajilic-Stojanovic et al., 2012).
Also, the diversity of bifidobacteria in the donors resembled
that observed for healthy adults by using the same PCR-DGGE
method (Satokari et al., 2001). Many of the recipient pre-FMT
samples were depleted on bifidobacteria as they were either
negative in the genus-specific PCR (7 out of 12 samples) or
yielded an amplification product only by using the more sensitive
nested PCR (3 out of 7 samples) (Supplementary Table 3). This
finding is in line with previous observations that CDI patients
have typically lower abundance of bifidobacteria as compared
to healthy individuals (Amrane et al., 2019). In contrast,
bifidobacterial PCR was successful with most recipient post-FMT
samples (80 out of 85), and the DGGE profiles indicated the
presence of multiple strains. In our previous study assessing
total microbiota changes in the same cohort of rCDI patients,
we observed over a 5-fold increase in the signal level from
bifidobacteria in the phylogenetic microarray analysis (Jalanka
et al., 2016). We revisited the microarray data and constituted
that the relative abundance of bifidobacteria in the majority of
our rCDI patients was below 0.8% before FMT, but increased to
an average 4% post-FMT, whereas the donors Y and X had∼2 and
8% relative abundance of bifidobacteria, respectively (data not
shown). Taken together, both the qualitative analysis performed
in this study and the previous semiquantitative results from the
phylogenetic microarray profiling indicate that FMT drastically
enriched bifidobacteria in the rCDI patients, in addition to the
total microbiota re-establishment.
The recipient samples clustered together with the respective
donor samples in the UPGMA analysis indicating a high
similarity in the bifidobacterial population structure. We
analyzed factors contributing to the grouping of post-FMT
recipient profiles together with the donor profiles and found the
band positions of donor B. longum strains to be major factors. As
the bands in the recipient post-FMT profiles matched to those
obtained from donor isolates, we found it plausible that they
represent transferred bifidobacteria. Some recipient post-FMT
profiles contained also unique community members, suggesting
that FMT may also have fostered the recovery of endogenous
bifidobacterial populations of the recipients. Previously, a mouse
model with CDI and severe dysbiosis showed that administration
of a bacterial cocktail of six species was able to trigger major shifts
in the microbial community structure and to induce the recovery
of endogenous microbiota (Lawley et al., 2012).
We cultivated bifidobacteria on selective MUP medium, which
promotes bifidobacterial growth very well while also being
selective for the genus (Quartieri et al., 2016). The samples for
cultivation were selected based on the profiling of bifidobacterial
populations with the aim of recovering donor-derived strains
from the recipients. The vast majority of the isolates were
identified as Bifidobacterium spp. by typical phenotypic traits
such as cell morphology as well as by partial 16S rRNA gene
sequencing. The isolates were subjected to molecular typing by
rep-PCR, which expectedly allowed separation below the species
level (Jarocki et al., 2016). Comparison of rep-PCR fingerprints
from the donor and recipient isolates revealed that all the
recipients carried some donor-like bifidobacterial strains after
FMT. Importantly, some of the donor-like strains present in the
recipient post-FMT samples could be isolated months or even a
year after the treatment and the strain identities were confirmed
by WGS analysis. It has been previously reported that stable
colonization of probiotic B. longum AH1206 depends on the
features of recipient gut microbiota as they define the ecological
niches present in the environment (Maldonado-Gomez et al.,
2016). Usually, allochthonous bifidobacteria introduced into the
adult gut, such as orally administered probiotic strains, are
typically lost after a few days or weeks without their continuous
influx (Satokari et al., 2001; Mättö et al., 2006). On the other
hand, B. longum has been documented to transmit vertically as
certain strains in mother’s feces or breast milk have been detected
in child’s fecal samples even up to 6 years after birth (Duranti
et al., 2017; Oki et al., 2018). Thus, bifidobacteria seem capable
of establishing themselves as permanent residents of the human
gut, at least during the development of gut microbiota when
an ecological niche is available. As rCDI patients usually have
aberrant and less abundant gut microbiota, it might provide
bifidobacteria with niches not necessarily present in healthy
microbiota. Indeed, a recent mouse study demonstrated that
antibiotic pre-treatment prior to FMT enhances specifically the
colonization of bifidobacteria (Freitag et al., 2019). In this study,
all the recipients were rCDI patients who had received multiple
antibiotic treatments before FMT, which may have contributed
to the observed colonization of bifidobacteria. Overall, rCDI
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patients have highly depleted microbiota with poor colonization
resistance capacity and the likelihood of stable strain colonization
is probably much higher than in healthy gut environment.
However, we isolated and identified strains with proven long-
term colonization capacity, but the capacity still needs to be
addressed in other populations than rCDI patients and with the
isolated strains available such further studies are feasible.
In order to verify the same origin of the isolated bifidobacterial
strains from the donors and recipients, we subjected 65 isolates
to WGS to compare their similarity by three different approaches
including phylogenomic, phylogenetic, and pangenomic analysis.
The isolate genome sizes, G+C contents, and predicted gene
numbers were similar to those obtained for fecal bifidobacteria
in previous studies (Duranti et al., 2017; Freitas and Hill, 2018).
In the phylogenomic and phylogenetic analysis, the isolates
clustered according to their rep-PCR fingerprints. We also
analyzed the relatedness of donor and recipient strains by whole
genome SNP calling with CSIPhylogeny tool, which is well
suited for example for outbreak surveillance based on whole
genome sequencing data (Kaas et al., 2014; Saltykova et al.,
2018). The tool is particularly well suited for closely related
strains as it provides more informative sites and detects more
feasibly high-quality SNPs for comparison (Kaas et al., 2014).
Here, we performed separate runs for B. adolescentis, B. longum,
and B. pseudocatenulatum isolates. Based on the analysis, several
B. longum strains of the donor DX and the B. longum strain
of the donor DY were very close relatives with multiple DX
and DY recipient isolates, respectively. Moreover, several isolates
originating from different time points from the same recipient
as well as isolates from different recipients who had received
FMT from the same donor were found to be closely related.
Similarly, B. adolescentis and B. pseudocatenulatum isolates from
the DX recipients were highly similar to the corresponding DX
isolates. While it is clear that isolates differing by only a few
SNPs, such as all the donor strains and majority of recipient
isolates in the DX-23 group, represent the same strain, we find
it likely that also the isolates differing up to several hundred SNPs
originate from the same strain. It should be noted that some of
the strains were recovered from the recipients months or even
a year after FMT and certainly genomic changes, such as those
seen in the SNP analysis, could have accumulated during that
time. Similarly, strains in a donor microbiota could have diverged
into several lineages from a single ancestor strain, which could
explain the SNP differences found among the strains isolated
from the same donor. Naturally, sequencing errors may also
contribute to the observed differences. The number of SNPs
between the NCBI RefSeq genomes or isolates obtained from the
different donors was ∼7000–8000, which shows that strains with
distinct origin could be clearly indicated. Regarding the strain
separation, there is no consensus defining the number of SNPs
that could differentiate one strain from another, and the results
are dependent on the species as well as on the quality of sequences
(Hilliard et al., 2018; Saltykova et al., 2018). Our analysis was
able to compare over two million sites from every isolate and
covered 99–100% of the whole genomes of B. adolescentis, 75–
96% of B. longum, and 82–99% of B. pseudocatenulatum, thus
giving good coverage of the genomes and great confidence of
the results. Furthermore, the pangenome analysis supported
the grouping based on the other methods. Taken together, the
comprehensive analysis of the bifidobacterial isolates confirmed
the same origin of several donor and recipient strains and showed
that specific strains transferred via FMT can persist in rCDI
patients for long term.
Here we used our previous clinical study on the FMT
treatment of rCDI patients (Jalanka et al., 2016) as a discovery
platform for isolating and selecting bifidobacterial strains with
proven capacity for long-term colonization, and confirmed by
WGS that the strains acquired by the recipients originated from
the donors. The most prominent colonizers belong to the species
B. longum in both donor-recipient groups. All DY recipients
carried similar B. longum strains 1 year after FMT, whereas DX
recipients had three different persistent strains. One DX recipient
had also acquired a donor-derived strain of B. adolescentis that
was detectable 1 year post-FMT. Interestingly, a recent study
combining both metagenomic and culturomic approaches found
that CDI patients lack two bifidobacterial species, B. adolescentis
and B. longum (Amrane et al., 2019). The observation is in
line with our results and is encouraging regarding the potential
use of these species in future bacteriotherapeutic applications.
In this regard, bifidobacteria have already a long history as
probiotics and many specific strains hold a “generally regarded
as safe” status (GRAS) in the United States and are on the
Qualitative Presumption of Safety (QPS) list in the European
Union, making their use easy and straightforward both in
probiotic foods and as therapeutic agents or supplements. In
fact, strains of Bifidobacterium have already been included in a
bacterial mix that was used to treat successfully two rCDI patients
(Petrof et al., 2013).
We demonstrate that FMT trials accompanied by microbiota
analysis can be used as discovery platforms to identify and
isolate bacteria that can effectively colonize dysbiotic human
gut and be used as novel probiotics for therapeutic purposes.
The results obtained can guide the design of further studies
focusing on bacteriotherapeutic cocktails based on in-vitro-
cultivated bacteria. Concerning the isolated strains, the most
obvious question to be addressed is the factors behind long-
term colonization. On the bacterial side, mechanisms mediating
adhesion to intestinal mucus and enterocytes as well as efficient
nutrient harvest in the very competitive gut environment can
contribute to successful colonization (Ventura et al., 2012). Our
pangenomic analysis revealed that, unlike the core genome,
the gene clusters unique to certain groups had no functional
annotation. Previously, Bottacini et al. (2014) hypothesized
that such unique parts of genomes may code for novel
Bifidobacterium-specific molecules involved in host-bacterial
interactions. While all our donor strains can be considered to be
well adapted to the gut environment as they showed remarkably
stable existence as part of bifidobacterial communities in
the donors, there was a clear difference in their long-term
colonization success across the recipients. We didn’t observe an
“all-or-none” mode of colonization of donor bifidobacteria in
the recipients, as was found for closely related strains by Smillie
et al. (2018). Indeed, the successful colonization seems to depend
on several factors including the bacterial species in question,
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possible competition or mutualism within the species as well
as the resident microbiota, and the immune responses of the
recipient, and thus, personalized approaches may also need to be
considered to achieve stable gut colonization.
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